CEBIPHAR Toulouse : Opening of a pharmaceutical establishment

CEBIPHAR gets authorization from ANSM and ANSES for the opening of a pharmaceutical establishment on Toulouse site

We are pleased to announce that after the launch of the CEBIPHAR Toulouse site in March 2019, we received the authorization to open a pharmaceutical establishment from the ANSM (French Human Health Agency) in July 2020 and from the ANSES (French Veterinary Health Agency) in September 2020. In order to obtain the GMP certification, the first inspection by the ANSES took place in Toulouse
in April 2021.

This allows us to achieve the 2 objectives that CEBIPHAR set for itself when creating this second site, namely:

• To secure your clinical and commercial supply chain, by offering 2 harmonized sites from an operational and Quality Assurance point of view, with a strategy of co-validation of analytical methods
• Maintain competitive project start timelines for analytical support projects thanks to the spread of laboratory workloads on 2 sites rather than one, with the flexibility of small scale teams

In addition to its technical expertise, CEBIPHAR’s operational teams place a high priority on customer service, proximity and availability. CEBIPHAR is able to adapt its organization specifically to your project.